sur GENEURO SA (EPA:GNRO)
Temporary suspension of trading of GeNeuro SA shares on Euronext Paris
On January 23, 2026, GeNeuro SA announced the temporary suspension of trading of its shares on Euronext Paris. This decision follows a request from the company pending a ruling from the Geneva Court of First Instance regarding its composition agreement.
GeNeuro SA, specializing in the development of treatments for neurodegenerative diseases, had obtained a four-month extension for its final composition moratorium in September 2025. The upcoming judgment could influence the restructuring of the company.
The verdict is expected on January 27, 2026, and will be officially announced. This process could lead to a recapitalization or restructuring of GeNeuro SA's debt.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de GENEURO SA